Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 46,500 shares, a drop of 24.0% from the February 13th total of 61,200 shares. Approximately 2.2% of the company’s shares are short sold. Based on an average trading volume of 27,200 shares, the short-interest ratio is presently 1.7 days.
Insider Transactions at Kewaunee Scientific
In other Kewaunee Scientific news, VP Douglas J. Batdorff sold 3,470 shares of Kewaunee Scientific stock in a transaction dated Monday, December 30th. The stock was sold at an average price of $65.50, for a total transaction of $227,285.00. Following the transaction, the vice president now owns 5,000 shares of the company’s stock, valued at $327,500. The trade was a 40.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Donald T. Gardner III sold 1,257 shares of the company’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the completion of the transaction, the chief financial officer now owns 21,358 shares in the company, valued at approximately $1,265,675.08. This represents a 5.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 10,144 shares of company stock valued at $629,216 over the last ninety days. Corporate insiders own 14.20% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of KEQU. De Lisle Partners LLP raised its holdings in shares of Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares in the last quarter. State Street Corp bought a new position in shares of Kewaunee Scientific during the 3rd quarter valued at $266,000. Barclays PLC bought a new position in shares of Kewaunee Scientific during the 3rd quarter valued at $121,000. Geode Capital Management LLC raised its holdings in shares of Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after purchasing an additional 900 shares in the last quarter. Institutional investors own 32.69% of the company’s stock.
Kewaunee Scientific Stock Down 2.7 %
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last released its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The company had revenue of $67.17 million during the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.
View Our Latest Research Report on Kewaunee Scientific
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Retail Sales Data Signals a Surge: The E-Commerce Stock Picks
- Why Invest in High-Yield Dividend Stocks?
- Qualcomm’s Low PE Ratio Makes It A Seriously Attractive Stock
- What Does Downgrade Mean in Investing?
- Dollar General Stock Jumps—Will Its Turnaround Plan Work?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.